A retrospective cohort study evaluating the predictive value of urinary L-FABP combined with the SOFA score for assessing COVID-19 severity
PLOS One · 2025
DOI: 10.1371/journal.pone.0331558 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, 2025. Verfasst von Kanako Terakawa und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, Fatty Acid-Binding Proteins, Organ Dysfunction Scores. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, National Center for Global Health and Medicine.
Abstract (Originalsprache)
Although the symptoms of Coronavirus Disease 2019 (COVID-19) omicron strains are generally mild, some individuals with initially mild symptoms later required supplemental oxygen or hospitalization, while others died, highlighting the importance of rapid diagnosis and early treatment for such patients. Therefore, this study evaluated the benefit of a combined approach to identify individuals at risk of severe illness due to COVID-19 using urinary L-type fatty acid-binding protein (L-FABP) levels and the Sequential Organ Failure Assessment (SOFA) scores calculated from blood tests for pre-admission screening of patients with COVID-19. L-FABP, a non-invasive urine biomarker, and the SOFA score, an established method for assessing organ failure severity, were evaluated in conjunction with patient data collected from 842 individuals admitted to a hospital in Tokyo, Japan. The combined approach demonstrated a higher accuracy in identifying patients at risk of severe illness compared to the L-FABP levels or SOFA scores alone. Thus, the results suggest that a two-tiered screening process, utilizing measurement of L-FABP levels as an initial rapid test, followed by SOFA score assessment for high-risk patients, results in efficient pre-admission screening and improved patient management. In conclusion, this study underscores the potential of combining L-FABP levels and SOFA scores for optimizing patient care during the ongoing COVID-19 pandemic, emphasizing the need for further validation and refinement of the predictive models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
- Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan.
- Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- Department of Respiratory Medicine, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- Central Biobank, National Center Biobank Network, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
ORCID-Profile: Daisuke Katagiri, Masayuki Hojo, Katsushi Tokunaga
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- National Center for Global Health and Medicine
Zitieren
APA
Terakawa, K., Katagiri, D., Asai, Y., Ishikane, M., Ohmagari, N., Suzuki, M., Hojo, M., Takano, H., Tokunaga, K., Sugaya, T., & Noiri, E. (2025). A retrospective cohort study evaluating the predictive value of urinary L-FABP combined with the SOFA score for assessing COVID-19 severity. PLOS One. https://doi.org/10.1371/journal.pone.0331558
Vancouver
Terakawa K, Katagiri D, Asai Y, Ishikane M, Ohmagari N, Suzuki M, et al. A retrospective cohort study evaluating the predictive value of urinary L-FABP combined with the SOFA score for assessing COVID-19 severity. PLOS One. 2025. doi:10.1371/journal.pone.0331558
BibTeX
@article{Terakawa2025,
author = {Terakawa, Kanako and Katagiri, Daisuke and Asai, Yusuke and Ishikane, Masahiro and Ohmagari, Norio and Suzuki, Minami and Hojo, Masayuki and Takano, Hideki and Tokunaga, Katsushi and Sugaya, Takeshi and Noiri, Eisei},
title = {A retrospective cohort study evaluating the predictive value of urinary L-FABP combined with the SOFA score for assessing COVID-19 severity},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331558}
}
EUVIMED